HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luoting Yu Selected Research

Caspase 9

1/2020YLZ-F5, a novel polo-like kinase 4 inhibitor, inhibits human ovarian cancer cell growth by inducing apoptosis and mitotic defects.
12/2014SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luoting Yu Research Topics

Disease

35Neoplasms (Cancer)
06/2022 - 06/2012
16Neoplasm Metastasis (Metastasis)
06/2022 - 01/2014
6Breast Neoplasms (Breast Cancer)
06/2022 - 01/2014
5Melanoma (Melanoma, Malignant)
06/2022 - 02/2016
2Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2020
2Carcinogenesis
08/2021 - 01/2019
2Inflammation (Inflammations)
07/2021 - 02/2017
2Lung Neoplasms (Lung Cancer)
01/2020 - 08/2013
2Colorectal Neoplasms (Colorectal Cancer)
11/2019 - 01/2014
2Triple Negative Breast Neoplasms
01/2019 - 01/2018
2Pancreatic Neoplasms (Pancreatic Cancer)
07/2016 - 12/2014
2Carcinoma (Carcinomatosis)
08/2013 - 05/2012
1Pulmonary Fibrosis (Fibrosing Alveolitis)
02/2022
1Diabetic Nephropathies (Diabetic Nephropathy)
02/2022
1Stomach Neoplasms (Stomach Cancer)
08/2021
1Fibrosis (Cirrhosis)
07/2021
1Lymphoma (Lymphomas)
01/2021
1Prostatic Neoplasms (Prostate Cancer)
01/2020
1Autoimmune Hepatitis
10/2019
1Hepatitis
10/2019
1Hepatitis C
09/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2019
1Brain Neoplasms (Brain Tumor)
01/2019
1Colonic Neoplasms (Colon Cancer)
09/2017
1Cardiovascular Diseases (Cardiovascular Disease)
02/2017
1Hematologic Neoplasms (Hematological Malignancy)
02/2017
1Nervous System Diseases (Neurological Disorders)
02/2017
1Obesity
02/2017
1Infections
01/2016
1Bacterial Infections (Bacterial Infection)
01/2016
1Lymphatic Metastasis
07/2015

Drug/Important Bio-Agent (IBA)

15Pharmaceutical PreparationsIBA
02/2022 - 01/2014
6Biological ProductsIBA
01/2022 - 02/2017
4Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2011
4Antipsychotic Agents (Antipsychotics)IBA
01/2021 - 01/2018
3nifuroxazide (Akabar)IBA
06/2022 - 02/2016
2Histone-Lysine N-MethyltransferaseIBA
03/2022 - 08/2019
2Therapeutic UsesIBA
02/2022 - 09/2017
2Bleomycin (Blenoxane)FDA LinkGeneric
02/2022 - 07/2021
2Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
08/2021 - 02/2014
2Trifluoperazine (Stelazine)FDA LinkGeneric
01/2021 - 01/2018
2Caspase 3 (Caspase-3)IBA
01/2020 - 01/2018
2Enhancer of Zeste Homolog 2 ProteinIBA
01/2020 - 02/2016
2Matrix Metalloproteinases (MMPs)IBA
01/2020 - 02/2016
2Phosphotransferases (Kinase)IBA
01/2020 - 10/2018
2Caspase 9IBA
01/2020 - 12/2014
2cryptotanshinoneIBA
12/2019 - 08/2016
2ZLD1039IBA
02/2016 - 01/2016
2N- methyl- 4- (4- (3- (trifluoromethyl)benzamido)phenoxy)picolinamide4- methylbenzenesulfonateIBA
07/2015 - 08/2013
1Hydroxyproline (4 Hydroxyproline)IBA
02/2022
1Focal Adhesion Protein-Tyrosine KinasesIBA
01/2022
1snake venom protein C activatorIBA
11/2021
1indium-bleomycinIBA
07/2021
1IndazolesIBA
04/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1CyclinsIBA
01/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020
1Androgen Antagonists (Antiandrogens)IBA
01/2020
1enzalutamideIBA
01/2020
1Penfluridol (Semap)IBA
01/2020
1Tubulin ModulatorsIBA
12/2019
1pectolinarigeninIBA
11/2019
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2019
1Alanine Transaminase (SGPT)IBA
10/2019
1Concanavalin AIBA
10/2019
1TriazolesIBA
10/2019
1pyridineIBA
10/2019
1Viral RNAIBA
09/2019
1Fluphenazine (Prolixin)FDA LinkGeneric
01/2019
1PDZ-binding kinaseIBA
01/2019
1Mitogen-Activated Protein KinasesIBA
01/2019
1Protein Kinases (Protein Kinase)IBA
01/2019
1Paclitaxel (Taxol)FDA LinkGeneric
09/2017
1Liposomes (Liposome)IBA
09/2017
1BenzenesulfonamidesIBA
02/2017
1YLT256IBA
07/2016
1EnzymesIBA
02/2016
1MethyltransferasesIBA
02/2016
1VimentinIBA
02/2016
1AntidiarrhealsIBA
02/2016
12- (2- methyl- 1,4- dioxa- 8- azaspiro(4.5)dec- 8- yl)- 8- nitro- 6- (trifluoromethyl)- 4H- 1,3- benzothiazin- 4- oneIBA
01/2016
1Anti-Bacterial Agents (Antibiotics)IBA
01/2016
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
07/2015
1Vascular Endothelial Growth Factor DIBA
07/2015
1benzothiazoleIBA
12/2014
1YLT192IBA
08/2014
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
08/2014
1AlginatesIBA
08/2014
1PD 173074IBA
02/2014
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
02/2014
1N- (5- bromopyridin- 2- yl)- 2- ((6- (2- chloroacetamido)benzo(d)thiazol- 2- yl)thio)acetamideIBA
01/2014

Therapy/Procedure

14Therapeutics
11/2021 - 06/2012
4Oral Administration
01/2020 - 08/2014
3Drug Therapy (Chemotherapy)
10/2018 - 08/2013
1Segmental Mastectomy (Lumpectomy)
06/2022
1Intraperitoneal Injections
02/2022
1Immunotherapy
01/2021
1Castration
01/2020